Article appraised François B, Bellissant E, Gissot V, et al; Association des Réanimateurs du Centre-Ouest (ARCO). 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet 2007; 369: 1083-9.
Structured abstractBackground: The efficacy of corticosteroids for reducing the incidence of post-extubation laryngeal edema remains controversial.Objective: To evaluate whether methylprednisolone (MP) started 12 hr prior to planned tracheal extubation, can prevent post-extubation laryngeal edema.Design: Prospective, randomized, blinded, placebocontrolled trial performed in 15 intensive care units (ICU) across France.Methods: Inclusion criteria were adult (age >18 yr) patients who were scheduled for planned tracheal extubation after having received mechanical ventilation for > 36 hr. Exclusion criteria included pregnancy, history of post-extubation upper-airway obstruction, primary ICU admission diagnosis of throat disease or surgery, tracheostomy, and those who had been chronically treated with non-steroidal anti-inflammatory drugs or corticosteroids. Patients were randomly allocated to receive either corticosteroid or placebo. Allocation was stratified by site, and was concealed in sequentially numbered sealed opaque envelopes. Analyses were performed on a per-protocol and intention-to-treat basis.Intervention: Patients were allocated to either intravenous MP 20 mg initiated 12 hr prior to planned tracheal extubation, and continued every four hours thereafter with the final dose given immediately prior to extubation (total dose 80 mg) or identical volume of intravenous placebo (normal saline).Primary endpoint: The primary endpoint was occurrence of laryngeal edema within 24 hr of planned tracheal extubation. Laryngeal edema was clinically